PriceTargets.com logo

Moelis & Company - MC Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $71.83
  • Forecasted Upside: 24.10%
  • Number of Analysts: 7
  • Breakdown:
  • 2 Sell Ratings
  • 4 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$57.88 As of 03/28/2025 04:59 PM ET
▼ -1.778 (-2.98%)

This chart shows the closing price for MC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
FebMar$59.72Closing price on 03/27/25:
Get New Moelis & Company Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MC

Analyst Price Target is $71.83
▲ +24.10% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Moelis & Company in the last 3 months. The average price target is $71.83, with a high forecast of $92.00 and a low forecast of $51.00. The average price target represents a 24.10% upside from the last price of $57.88.

This chart shows the closing price for MC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
3/246/249/2412/243/254/26$34$49$63$78$92Closing price on 03/27/25: $59.72High$92.00Average$71.83Low$51.00




Current Consensus is Reduce

The current consensus among 7 investment analysts is to reduce stock in Moelis & Company. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 4 sell ratings
Ratings as of
10/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
Ratings as of
1/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
4/2/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
7/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
9/29/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
12/28/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
2/26/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
3/28/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/14/2025The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$86.00 ➝ $75.00
3/13/2025Morgan StanleyReiterated RatingOverweight ➝ Underweight$100.00 ➝ $70.00
2/6/2025The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$79.00 ➝ $87.00
2/6/2025Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Outperform$86.00 ➝ $92.00
2/6/2025JMP SecuritiesReiterated RatingMarket Perform ➝ Market Perform
2/6/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$77.00 ➝ $83.00
2/6/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$95.00 ➝ $100.00
1/14/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$78.00 ➝ $77.00
12/20/2024Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$71.00 ➝ $86.00
12/12/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$70.00 ➝ $78.00
12/9/2024Morgan StanleyUpgradeUnderweight ➝ Overweight$66.00 ➝ $92.00
10/24/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$67.00 ➝ $66.00
10/8/2024UBS GroupBoost TargetSell ➝ Sell$54.00 ➝ $60.00
9/23/2024Morgan StanleyBoost TargetUnderweight ➝ Underweight$61.00 ➝ $67.00
9/12/2024Wells Fargo & CompanyInitiated CoverageEqual Weight$70.00
7/25/2024Keefe, Bruyette & WoodsReiterated RatingMarket Perform ➝ Market Perform$54.00 ➝ $60.00
7/25/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$50.00 ➝ $51.00
7/23/2024Morgan StanleyBoost TargetUnderweight ➝ Underweight$51.00 ➝ $61.00
7/11/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$54.00 ➝ $50.00
7/9/2024UBS GroupBoost TargetSell ➝ Sell$47.00 ➝ $50.00
4/25/2024UBS GroupBoost TargetSell ➝ Sell$45.00 ➝ $47.00
4/25/2024Keefe, Bruyette & WoodsReiterated RatingMarket Perform ➝ Market Perform$58.00 ➝ $54.00
4/9/2024JMP SecuritiesReiterated RatingMarket Perform
3/26/2024UBS GroupLower TargetSell ➝ Sell$46.00 ➝ $45.00
3/13/2024The Goldman Sachs GroupUpgradeSell ➝ Neutral$53.00 ➝ $58.00
2/8/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$46.00 ➝ $57.00
1/29/2024Keefe, Bruyette & WoodsReiterated RatingMarket Perform$56.00
12/19/2023The Goldman Sachs GroupBoost TargetSell ➝ Sell$41.00 ➝ $47.00
11/3/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$39.00 ➝ $38.00
10/3/2023UBS GroupBoost TargetSell ➝ Sell$29.00 ➝ $30.00
4/12/2023Morgan StanleyLower TargetUnderweight$30.00 ➝ $29.00
2/9/2023The Goldman Sachs GroupBoost TargetSell$38.00 ➝ $42.00
1/11/2023The Goldman Sachs GroupDowngradeNeutral ➝ Sell$40.00 ➝ $37.00
1/9/2023UBS GroupLower TargetSell$32.00 ➝ $30.00
11/3/2022JPMorgan Chase & Co.Lower TargetNeutral$42.00 ➝ $40.00
11/3/2022Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$40.00 ➝ $37.00
10/7/2022The Goldman Sachs GroupLower TargetNeutral$43.00 ➝ $38.00
9/23/2022UBS GroupDowngradeNeutral ➝ Sell$43.00 ➝ $35.00
7/28/2022UBS GroupBoost TargetNeutral$40.00 ➝ $43.00
7/18/2022Morgan StanleyDowngradeEqual Weight ➝ Underweight$53.00 ➝ $36.00
7/11/2022Wolfe ResearchDowngradePeer Perform ➝ Underperform$42.00
7/8/2022Piper SandlerLower TargetNeutral$50.00 ➝ $45.00
7/6/2022UBS GroupDowngradeBuy ➝ Neutral$54.00 ➝ $40.00
4/28/2022Piper SandlerDowngradeOverweight ➝ Neutral$52.00 ➝ $50.00
4/12/2022The Goldman Sachs GroupLower TargetNeutral$50.00 ➝ $45.00
4/7/2022Piper SandlerLower TargetOverweight$61.00 ➝ $52.00
4/6/2022Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$57.00
3/9/2022Piper SandlerLower TargetOverweight ➝ Overweight$70.00 ➝ $61.00
3/8/2022Morgan StanleyLower TargetEqual Weight$65.00 ➝ $53.00
2/11/2022Piper SandlerUpgradeNeutral ➝ Overweight$78.00 ➝ $70.00
2/10/2022Morgan StanleyLower TargetEqual Weight$68.00 ➝ $65.00
1/6/2022The Goldman Sachs GroupUpgradeSell ➝ Neutral$68.00 ➝ $65.00
1/4/2022UBS GroupLower TargetBuy$85.00 ➝ $73.00
12/17/2021Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$77.00
12/8/2021Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$75.00 ➝ $68.00
10/11/2021Morgan StanleyBoost TargetEqual Weight$63.00 ➝ $68.00
7/22/2021Morgan StanleyBoost TargetEqual Weight$60.00 ➝ $63.00
6/17/2021Wolfe ResearchUpgradeUnderperform ➝ Peer Perform$63.00
4/15/2021JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Perform
4/9/2021JMP SecuritiesDowngradeOutperform ➝ Market Perform
4/7/2021Morgan StanleyBoost TargetEqual Weight$57.00 ➝ $60.00
3/16/2021Piper SandlerBoost Target$58.00 ➝ $68.00
2/11/2021Morgan StanleyBoost TargetEqual Weight$55.00 ➝ $57.00
1/11/2021Morgan StanleyBoost TargetEqual Weight$52.00 ➝ $55.00
1/7/2021JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$34.00 ➝ $50.00
1/5/2021UBS GroupUpgradeNeutral ➝ Buy$40.00 ➝ $56.00
12/14/2020Morgan StanleyBoost TargetEqual Weight$41.00 ➝ $52.00
10/27/2020Piper SandlerBoost TargetNeutral$37.00 ➝ $41.00
10/12/2020Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $41.00
10/9/2020JMP SecuritiesBoost TargetMarket Outperform$37.00 ➝ $42.00
10/9/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$40.00
10/2/2020UBS GroupUpgradeSell ➝ Neutral$38.00
8/5/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell$27.00 ➝ $24.00
7/30/2020Piper SandlerLower TargetNeutral$32.00 ➝ $31.00
7/30/2020Morgan StanleyLower TargetEqual Weight$31.00 ➝ $29.00
7/22/2020Wolfe ResearchInitiated CoverageUnderperform$19.00
7/13/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$34.00 ➝ $27.00
7/10/2020Piper SandlerDowngradeOverweight ➝ Neutral$40.00 ➝ $32.00
7/7/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$20.00 ➝ $26.00
4/14/2020UBS GroupDowngradeNeutral ➝ Sell$22.00
4/9/2020JMP SecuritiesLower TargetMarket Outperform$45.00 ➝ $39.00
4/9/2020Morgan StanleyLower TargetEqual Weight$37.00 ➝ $31.00
(Data available from 3/29/2020 forward)

News Sentiment Rating

1.28 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/30/2024
  • 12 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/29/2024
  • 15 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/29/2024
  • 20 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2024
  • 23 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/28/2024
  • 8 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/27/2025
  • 23 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/26/2025
  • 29 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
3/28/2025

Current Sentiment

  • 29 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Moelis & Company logo
Moelis & Co. operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments. The company was founded by Kenneth David Moelis, Navid Mahmoodzadegan, Jeffrey Raich and Elizabeth Ann Crain in July 2007 and is headquartered in New York, NY.
Read More

Today's Range

Now: $57.88
Low: $57.34
High: $60.36

50 Day Range

MA: $70.16
Low: $57.88
High: $81.24

52 Week Range

Now: $57.88
Low: $46.24
High: $82.89

Volume

705,590 shs

Average Volume

695,172 shs

Market Capitalization

$4.34 billion

P/E Ratio

32.89

Dividend Yield

4.13%

Beta

1.43

Frequently Asked Questions

What sell-side analysts currently cover shares of Moelis & Company?

The following equities research analysts have issued reports on Moelis & Company in the last year: JMP Securities, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, StockNews.com, The Goldman Sachs Group, Inc., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for MC.

What is the current price target for Moelis & Company?

0 Wall Street analysts have set twelve-month price targets for Moelis & Company in the last year. Their average twelve-month price target is $71.83, suggesting a possible upside of 24.1%. Keefe, Bruyette & Woods has the highest price target set, predicting MC will reach $92.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $51.00 for Moelis & Company in the next year.
View the latest price targets for MC.

What is the current consensus analyst rating for Moelis & Company?

Moelis & Company currently has 2 sell ratings, 4 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for MC.

What other companies compete with Moelis & Company?

Other companies that are similar to Moelis & Company include The Carlyle Group, Futu, Healthpeak Properties, Gaming and Leisure Properties and American Homes 4 Rent. Learn More about companies similar to Moelis & Company.

How do I contact Moelis & Company's investor relations team?

Moelis & Company's physical mailing address is 399 PARK AVENUE 5TH FLOOR, NEW YORK NY, 10022. The asset manager's listed phone number is (212) 883-3800 and its investor relations email address is investor.relations@moelis.com. The official website for Moelis & Company is www.moelis.com. Learn More about contacing Moelis & Company investor relations.





Receive Moelis & Company News & Ratings Daily
Sign up to receive the latest news and ratings for Moelis & Company and its competitors with PriceTargets.com’s free daily newsletter.